Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04677504
Title A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

cholangiocarcinoma

gallbladder carcinoma

biliary tract cancer

Therapies

Atezolizumab + Cisplatin + Gemcitabine

Atezolizumab + Bevacizumab + Cisplatin + Gemcitabine

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.